The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Nobuaki Matsubara
Honoraria - Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Janssen; Lilly; Pfizer; Sanofi; Seagen
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer Yakuhin (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Eisai (Inst); Janssen (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst); Takeda (Inst)
 
Teresa Alonso Gordoa
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Astellas Pharma; Bayer; Eisai; Ipsen; Janssen-Cilag; Lilly; MSD Oncology; Pfizer; Recordati
Research Funding - Ipsen; Janssen Oncology
Travel, Accommodations, Expenses - Bayer; Ipsen
 
Victor Moreno
Employment - START
Consulting or Advisory Role - Abbvie; Affimed Therapeutics; AstraZeneca; Basilea; Bayer; BMS; Ellipses Pharma; Janssen Oncology; Merck; Roche
Speakers' Bureau - Bayer; Pierre Fabre
Research Funding - Abbvie (Inst); ACEA Biosciences (Inst); Adaptimmune (Inst); ADC Therapeutics (Inst); Amgen (Inst); Ascendis Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bicycle Therapeutics (Inst); Bioinvent (Inst); Biomea Fusion (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); C4 Therapeutics (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); Crescendo Bioscience (Inst); Cullinan Oncology (Inst); E-therapeutics (Inst); Eisai (Inst); F-Star Biotechnology (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Grey Wolf Therapeutics (Inst); hemavant (Inst); HiFiBiO Therapeutics (Inst); Janssen (Inst); Kinnate Biopharma (Inst); Menarini (Inst); Merck (Inst); MonTa Biosciences (Inst); Nanobiotix (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); PsiOxus Therapeutics (Inst); Puma Biotechnology (Inst); Regeneron (Inst); Revolution Medicines (Inst); RigonTEC (Inst); Roche (Inst); Sanofi (Inst); Sierra Oncology (Inst); Synthon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tesaro (Inst); Transgene (Inst)
Expert Testimony - Medscape/Bayer; Nanobiotix
Travel, Accommodations, Expenses - Sanofi/Regeneron
Other Relationship - BMS
 
Adanma Ayanambakkam
Consulting or Advisory Role - AVEO; Johnson and Johnson; Kura Oncology; Pfizer/Astellas
Research Funding - Regeneron
Travel, Accommodations, Expenses - Kura Oncology
 
Joan Carles
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Astellas Pharma; AstraZéneca; Bayer; Bristol-Myers Squibb; Exelixis; Ipsen; Johnson & Johnson/Janssen; MSD Oncology; Pfizer; Roche; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Johnson & Johnson
Travel, Accommodations, Expenses - AstraZeneca; BMS; Ipsen; Roche
Other Relationship - Catalan Program of Ambulatory Medication Comission (CAHMDA)
 
Richard Frank
No Relationships to Disclose
 
Kamil Kuc
Research Funding - Abbvie; Amgen; Astellas Pharma; AstraZeneca; BioNTech SE; Dizal Pharma; GlaxoSmithKline; MSD; Pfizer
Travel, Accommodations, Expenses - Amgen; Bayer; BMS GmbH & Co. KG; MSD; MSD; MSD; Swixx BioPharma; Takeda
 
Irene Moreno
Consulting or Advisory Role - BOXER CAPITAL LLC; ELLIPSES PHARMA; Guidepoint Global
Speakers' Bureau - Getthi group
Research Funding - DIGICORE (IDEAL4RWE); FUNDACIÓN INTHEOS
 
Fabricio Racca
No Relationships to Disclose
 
Michael Schweizer
Consulting or Advisory Role - Daiichi Sankyo/UCB Japan; FibroGen; Janssen; K36 Therapeutics; Pfizer
Research Funding - Ambrx (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Epigenetix (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Oric Pharmaceuticals (Inst); Pfizer (Inst); Roche (Inst); SignalOne Bio (Inst); Xencor (Inst); Zenith Epigenetics (Inst)
 
Qiang Wei
No Relationships to Disclose
 
Rajendar Mittapalli
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Jessica Tougias
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - Carrick Therapeutics
Research Funding - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Claudia Andreu-Vieyra
Employment - Pfizer
Stock and Other Ownership Interests - Johnson & Johnson; Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Neelesh Soman
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Jayeta Chakrabarti
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer